MLCI

On the surface MLCI looks statistically cheap: a 0.7x P/S and a $38.6M market cap against $91.0M of stated equity (≈0.42x book), with revenue growing a steady 7.6% to $53.6M and $2.1B of largely permanent/semi-permanent AUM generating recurring management and fee-related earnings (FRE). That is the entire bull case, and it is not enough. The company is two businesses stapled together — an asset manager (ML Management) and Ability Insurance, a Nebraska annuity reinsurer that also 'holds a run-off book of long-term care policies.' Long-term-care run-off is one of the most reserve-toxic liabilities in insurance, and nothing in the provided data lets an outside investor assess reserve adequacy on a $1.51B liability stack sitting atop just $91.0M of equity (16.6x liabilities/equity).

The numbers say the deterioration is real and accelerating, not a one-off. Net income collapsed to -$60.8M from -$10.4M a year earlier (-485.8%), diluted EPS was -$7.08, net margin was -113.6% and ROE -66.9%. A $60.8M loss against $91.0M of equity is a near two-thirds capital event in a single year; equity fell only 12.6% ($104M→$91M), which means something outside the income statement (OCI moves or fresh capital) partly plugged the hole — a dynamic the filing narrative does not explain and the retail investor cannot see. Retained earnings are -$121M and worsening (-107.2%). Operating cash flow was -$22.2M; it 'improved' 41% only because it started from a deeper hole, and it is still negative.